
29 Mar 2022
PCRonline @ ACC 2022 Scientific Sessions
The Interventional Cardiology perspective!
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
Mirvat Alasnag, Elad Asher, Luigi Biasco, Francesco Costa, Pierre Deharo, Giuseppe Di Gioia, Daniele Giacoppo, Dejan Milasinovic, Ali Nazmi Calik, Luis Ortega-Paz, Michele Pighi, Nicola Ryan and Alessandro Sticchi will provide their take on what's new and what's hot in the field of interventional cardiology at ACC.22 and they will offer you condensed take-home messages, live from the congress on-site and online. Be ready!
Late-breaking Clinical Trials and Science to be covered:
- Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People
- COMPLETE: Effects of Complete Revascularization on Angina-related Quality of Life in Patients With St-segment Elevation Myocardial Infarction
- The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery
- Results of the EDIT-CMD Randomized Clinical Trial: Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in Angina and Nonobstructive Coronary Arteries
- PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial
- Residual Leaks Post Left Atrial Appendage Occlusion
- One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation
- Insights From the Corevalve US Pivotal and SURTAVI Trials: Five-year Incidence, Timing and Predictors of Hemodynamic Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses
- A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement
- GHATI: Improving STEMI Management Internationally: Two-year Report of 4,015 Patients Enrolled in the American College of Cardiology - Global Heart Attack Treatment Initiative
- The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
- 3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
This independent ACC 2022 Coverage is available thanks to the unrestricted support of Medtronic